Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Fletcher

Showing results (81-90 of 205) with videos related to

Pageof 21
Sort By:
Cancer Research|March 18, 2004
USP6 (Tre2) fusion oncogenes in aneurysmal bone cystAndre M Oliveira, Bae-Li Hsi, Stanislawa Weremowicz, et al.
Molecular Cancer Therapeutics|June 6, 2012
Sorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumorsMichael C Heinrich, Adrian Marino-Enriquez, Ajia Presnell, et al.
Human Pathology|November 13, 2020
Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesisCher-Wei Liang, Ching-Yao Yang, Richard Flavin, et al.
The American Journal of Pathology|October 29, 2004
USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cystsAndre M Oliveira, Antonio R Perez-Atayde, Carrie Y Inwards, et al.
Plos One|June 5, 2012
p53 modulation as a therapeutic strategy in gastrointestinal stromal tumorsJoern Henze, Thomas Mühlenberg, Susanne Simon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 11, 2012
MED12 mutations in leiomyosarcoma and extrauterine leiomyomaGloria Ravegnini, Adrian Mariño-Enriquez, Jaime Slater, et al.
British Journal of Haematology|October 4, 2005
Distinctive IGH gene segment usage and minimal residual disease detection in infant acute lymphoblastic leukaemiasAihong Li, Meredith A Goldwasser, Jianbiao Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
Phosphoinositide 3-kinase inhibitors combined with imatinib in patient-derived xenograft models of gastrointestinal stromal tumors: rationale and efficacyThomas Van Looy, Agnieszka Wozniak, Giuseppe Floris, et al.
Journal of Translational Medicine|February 26, 2013
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumorSteven C Katz, Rachel A Burga, Seema Naheed, et al.
Current Protocols in Human Genetics|April 23, 2008
Reporting of diagnostic cytogenetic resultsAzra H Ligon, Cynthia C Morton, Frederick R Bieber, et al.
Pageof 21

Showing results (81-90 of 205) with videos related to

Sort By:
Pageof 21
Cancer Research|March 18, 2004
USP6 (Tre2) fusion oncogenes in aneurysmal bone cystAndre M Oliveira, Bae-Li Hsi, Stanislawa Weremowicz, et al.
Molecular Cancer Therapeutics|June 6, 2012
Sorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumorsMichael C Heinrich, Adrian Marino-Enriquez, Ajia Presnell, et al.
Human Pathology|November 13, 2020
Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesisCher-Wei Liang, Ching-Yao Yang, Richard Flavin, et al.
The American Journal of Pathology|October 29, 2004
USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cystsAndre M Oliveira, Antonio R Perez-Atayde, Carrie Y Inwards, et al.
Plos One|June 5, 2012
p53 modulation as a therapeutic strategy in gastrointestinal stromal tumorsJoern Henze, Thomas Mühlenberg, Susanne Simon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 11, 2012
MED12 mutations in leiomyosarcoma and extrauterine leiomyomaGloria Ravegnini, Adrian Mariño-Enriquez, Jaime Slater, et al.
British Journal of Haematology|October 4, 2005
Distinctive IGH gene segment usage and minimal residual disease detection in infant acute lymphoblastic leukaemiasAihong Li, Meredith A Goldwasser, Jianbiao Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
Phosphoinositide 3-kinase inhibitors combined with imatinib in patient-derived xenograft models of gastrointestinal stromal tumors: rationale and efficacyThomas Van Looy, Agnieszka Wozniak, Giuseppe Floris, et al.
Journal of Translational Medicine|February 26, 2013
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumorSteven C Katz, Rachel A Burga, Seema Naheed, et al.
Current Protocols in Human Genetics|April 23, 2008
Reporting of diagnostic cytogenetic resultsAzra H Ligon, Cynthia C Morton, Frederick R Bieber, et al.
Pageof 21